Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for ...

Dr Sunil Chumber, Professor and Head, Department of Surgical Disciplines, AIIMS, reveals to Rediff Senior Contributor Shobha ...

Fox Chase Cancer Center researchers reported positive results from the trial, known as RETAIN-2, demonstrating that a response-adapted ...

Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence ...

Deion Sanders' doctor reveals the Colorado coach nearly lost his leg following blood clot surgery during the 2025 season.

In the world of surgical robots, there’s a new kid in town, and Atrium Health Wake Forest Medical Center is one of the first ...

To further complicate clinicians’ treatment decisions, Padcev-Keytruda has become the new standard of care in first-line metastatic bladder cancer, raising the possibility that some physicians might ...

Chief Executive Officer Ron Cooper outlined the company’s near-term regulatory and clinical plans for its lead program, ...

Shares in ImmunityBio rose sharply after the company said it has agreed a path with the FDA that will allow it to refile for approval of wider use of its bladder cancer therapy, Anktiva, in ...

Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...

Lupita Nyong’o is speaking out about uterine fibroids and how little research has been done on noninvasive treatments. For ...

Once hailed as a “gold standard” treatment for women after childbirth, vaginal mesh implants have become one of the biggest medical scandals ...